Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications.

"all fecal metagenomic and metabolomic data in the covid-19 patients and control individuals were deposited and are available in the ddbj/genbank/embl (accession number: dra013706 ) and riken drop met (accession number: dm0042) respectively."

"Conflicts of interest These authors disclose the following: Naoyoshi Nagata, Wataru Suda, Moto Kimura, and Hiroshi Ohno received a grant from Ezaki Glico Co, Ltd. Ryo Aoki, Tomohiko Nishijima, and Hiroshi Inooka are employees of Ezaki Glico Co, Ltd. The remaining authors disclose no conflicts."

"Funding This work was partially supported by grants from Ezaki Glico Co, Ltd; Grants-in-Aid for Research from the National 10.13039/100012319Center for Global Health and Medicine (28-2401); a 10.13039/501100001691JSPS KAKENHI grant (JP17K09365 and 20K08366); the Takeda Science Foundation; COCKPIT funding; the 10.13039/100009619Japan Agency for Medical Research and Development (JP20fk0108416); The Ministry of Health, Labor, and Welfare (22HB1003); the RIKEN President’s Discretionary Funds; and the 10.13039/100013107RIKEN 10.13039/501100006322IMS Center Director’s Discretionary Budget, Japan. The funders played no role in the study design, data collection, decision to publish, or preparation of the manuscript."